ZubinMinooBhagwagarMD

Associate Professor (adjunct), Department of Psychiatry, Yale School of Medicine

Dr. Bhagwagar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
800 Howard Ave
Yale Physicians Bldg
New Haven, CT 06519
Phone+1 203-785-2140

Fax+1 203-785-6414

Ceftriaxone in the Management of Bipolar Depression Start of enrollment: 2007 Sep 01
Terminated
Not Applicable
Levetiracetam in the Management of Bipolar Depression Start of enrollment: 2005 Oct 01
Completed
Not Applicable

PubMed

3 citations
An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-ce...
Christof Geisen, Mette Kjaer, Erika Fleck, Bjorn Skogen, Róisín Armstrong
Journal of Thrombosis and Haemostasis. 2023-04-01
6 citations
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations.
Bethea A. Kleykamp, Robert H. Dworkin, Dennis C. Turk, Zubin Bhagwagar, Penney Cowan
Pain. 2021-09-09
84 citations
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.
Shannon M. Smith, Robert H. Dworkin, Dennis C. Turk, Michael P. McDermott, Christopher Eccleston
Pain. 2020-11-01

Rallybio Expands Drug Acquisition and Development Capabilities with Addition of Veteran Industry ExecutivesJuly 10th, 2018

A Study Of GABA And 5-HT Interactions To Test A Molecular Model Of VulnerabilityNational Institute Of Mental Health2007–2009